Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
626 participants
INTERVENTIONAL
2008-09-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Compare the Clinical Efficacy of Prototype Toothpastes
NCT00926029
Compare the Clinical Efficacy of Prototype Toothpastes.
NCT00761930
Clinical Efficacy of a Toothpaste on Hypersensitivity Reduction
NCT01040169
Development of Clinical Method to Determination Triclosan Retention in Plaque Following Brushing.
NCT00966953
Comparative Efficacy of a Toothpaste That Reduces Plaque and Gingivitis
NCT00926328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
sensitive toothpaste
Triclosan, Silicon dioxide, fluoride
Brush twice daily
B
Triclosan control toothpaste
Triclosan, fluoride
Brush twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Triclosan, Silicon dioxide, fluoride
Brush twice daily
Triclosan, fluoride
Brush twice daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Availability for the eight-week duration of the study.
* Two sensitive teeth, which must be anterior to the molars, and demonstrate cervical erosion/abrasion or gingival recession.
* Qualifying response to Tactile stimuli (Yeaple Probe) as defined by a score between 10-50 grams of force.
* Qualifying response to the Air Blast stimuli as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale.
* Subjects need to satisfy the qualifying response to stimuli for both parameters assessed (Tactile or Air Blast) on at least two teeth to be entered into the study.
* Good general health with no known allergies to products being tested.
* Use of a non-desensitizing dentifrice for one month prior to entry into the study.
* Signed Informed Consent Form.
Exclusion Criteria
* Advanced periodontal disease or treatment for periodontal disease (including surgery) within the past twelve months.
* Sensitive teeth with a mobility greater than one.
* Teeth with extensive/defective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures.
* Regular use of anticonvulsants, antihistamines, sedatives, tranquilizers, anti-inflammatory drugs, or analgesics.
* Participation in a desensitizing dentifrice study or regular use of a desensitizing dentifrice within the past one month.
* Current participation in any other clinical study.
* Allergies to triclosan, or oral care products, personal care consumer products, or their ingredients.
* Medical condition which prohibits not eating/drinking for 4 hours.
12 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Colgate Palmolive
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Augusto Elias, DDS
Role: PRINCIPAL_INVESTIGATOR
Univ of Puerto Rico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Concordia Clinical Research
Cedar Knolls, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRO-0208-TOT-SEN-PR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.